|
|||||||||||||||||||||||||||||||||||
|
2 Reviews
|
Average Customer Review
Share your thoughts with other customers
Create your own review
|
|
Most Helpful First | Newest First
|
|
7 of 7 people found the following review helpful:
1.0 out of 5 stars
This Psychiatry Textbook Brought to You (and Written By) GlaxoSmithKline,
By
This review is from: Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care (Paperback)
The New York Times reported today this textbook was ghostwritten by GlaxoSmithKline. It is tainted by Big Pharma influence. Stay away.
2 of 2 people found the following review helpful:
1.0 out of 5 stars
Big Pharma paying Big Bucks to Big Profs.,
By
This review is from: Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care (Paperback)
But the drug maker, then known as SmithKline Beecham, actually had much more involvement than the book described, newly disclosed documents show. The grant paid for a writing company to develop the outline and text for the two named authors, the documents show, and then the writing company said it planned to show three drafts directly to the pharmaceutical company for comments and proposed a timeline for the writing company to furnish the doctors and SmithKline with draft text and final page proofs for approval.
"That doesn't sound unrestricted to me," Dr. Bernard Lo, a medical ethicist and chairman of an Institute of Medicine group that wrote a 2009 report on conflicts of interest, said after reviewing the documents. "That sounds like they have ultimate control." - The New York Times By DUFF WILSON Published: November 29, 2010 |
|
Most Helpful First | Newest First
|
|
Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care by Charles B. Nemeroff (Paperback - December 15, 1999)
$78.00
Temporarily out of stock. Order now and we'll deliver when available. | |
 
| ||
